Tricyclic BTK degraders and their pharmaceutical applications
TW202637182APending Publication Date: 2026-09-16HAISCO PHARMACEUTICAL GROUP CO LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114147398
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-12-05
- Filing Date
- 2025-12-04
- Publication Date
- 2026-09-16
Abstract
Tricyclic BTK degrading agents and their pharmaceutical applications, specifically relating to a compound of general formula (I-1), (I-2), (I-3), or (I-4) or its stereoisomers, tautomers, racemates, pharmaceutically acceptable salts, intermediates, and preparation methods thereof, and their use in BTK-related diseases such as tumors or autoimmune diseases, particularly in relapsed / refractory B-cell malignancies.
Need to check novelty before this filing date? Find Prior Art